Department of Ophthalmology, Glostrup Hospital, Nordre Ringvej 57, 2600 Glostrup, Denmark.
Pediatrics. 2011 Mar;127(3):e598-606. doi: 10.1542/peds.2010-1974. Epub 2011 Feb 14.
The aim of this study was to uncover the most effective and safe criterion to implement for retinopathy of prematurity screening in Denmark.
This retrospective national cohort study is based on data from 3 national registers. These registers provided on infants treated for retinopathy of prematurity, infants in need of treatment but missed by the present screening program, and the candidate neonates for advanced retinopathy of prematurity development A nonlinear logistic regression model was fitted to the data, and various screening criteria were evaluated.
During the study period (2002-2006), 116 infants were treated for retinopathy of prematurity, no treatment-demanding retinopathy of prematurity infants were missed by the screening program, and 182 premature infants were candidates for developing treatment-demanding retinopathy of prematurity. Screening criteria combining gestational age at delivery and birth weight limits and new risk-based criteria were compared with regards to their effectiveness. The risk-based criteria were the most effective. Use of the 0.13% risk-based criterion to define the population to be screened resulted in the detection of all treated infants in the study period and 17.4% fewer infants to screen. The model predicted this criterion to result in 1 missed case of treatment-demanding retinopathy of prematurity every 11 years and 1 case of blindness every 18 years in Denmark.
Screening criteria based on risk estimates of developing treatment-demanding retinopathy of prematurity are the most effective for retinopathy-of-prematurity screening. The risk-based criterion of 0.13% can safely be implemented for future retinopathy-of-prematurity screening in Denmark.
本研究旨在揭示丹麦早产儿视网膜病变筛查中实施最有效和最安全标准。
本回顾性全国队列研究基于来自 3 个国家登记处的数据。这些登记处提供了接受早产儿视网膜病变治疗的婴儿、本筛查方案漏诊但需要治疗的婴儿以及候选早产儿视网膜病变进展的婴儿。采用非线性逻辑回归模型对数据进行拟合,并评估了各种筛查标准。
在研究期间(2002-2006 年),116 名婴儿接受了早产儿视网膜病变治疗,筛查方案未漏诊需要治疗的早产儿视网膜病变婴儿,182 名早产儿候选发展为需要治疗的早产儿视网膜病变。比较了结合分娩时胎龄和出生体重限制的筛查标准和新的基于风险的标准,评估了它们的有效性。基于风险的标准是最有效的。使用 0.13%的基于风险的标准来定义需要筛查的人群,结果是检测到了研究期间所有接受治疗的婴儿,而需要筛查的婴儿减少了 17.4%。该模型预测,该标准将导致丹麦每 11 年漏诊 1 例需要治疗的早产儿视网膜病变,每 18 年漏诊 1 例失明。
基于发展为需要治疗的早产儿视网膜病变风险估计的筛查标准对早产儿视网膜病变筛查最有效。0.13%的基于风险的标准可安全用于丹麦未来的早产儿视网膜病变筛查。